Amneal Pharmaceuticals, Inc. (AMRX)

Sage Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 5, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,548	2,454	1,861	301	715	675
Market Cap Growth	29.37%	31.88%	517.29%	-57.87%	6.05%	4.38%
Enterprise Value	5,060	5,081	4,434	2,989	3,372	3,471
Last Close Price	7.96	7.92	6.07	1.99	4.79	4.57
PE Ratio	749.38	-	-	-	67.35	7.41
Forward PE	11.64	11.69	11.92	2.71	5.65	7.07
PS Ratio	0.87	0.88	0.78	0.14	0.34	0.34
PB Ratio	-	-55.10	30.35	1.44	1.86	1.89
P/FCF Ratio	9.41	10.45	6.23	18.49	3.75	2.13
P/OCF Ratio	7.26	8.32	5.38	4.63	2.96	1.78
PEG Ratio	-	0.66	0.66	0.66	0.66	2.65
EV/Sales Ratio	1.77	1.82	1.85	1.35	1.61	1.74
EV/EBITDA Ratio	8.09	8.69	8.85	6.79	7.49	9.11
EV/EBIT Ratio	13.32	14.59	16.34	14.94	15.57	23.83
EV/FCF Ratio	18.68	21.64	14.84	183.29	17.67	10.94
Debt / Equity Ratio	-55.25	-58.22	44.87	13.62	7.52	8.41
Debt / EBITDA Ratio	4.00	4.28	5.26	6.15	6.15	7.36
Debt / FCF Ratio	9.53	11.05	9.21	174.50	15.13	9.46
Asset Turnover	0.82	0.80	0.66	0.57	0.53	0.52
Inventory Turnover	3.01	2.98	2.75	2.79	2.67	3.08
Quick Ratio	0.80	0.82	0.87	1.10	1.39	1.49
Current Ratio	1.43	1.41	1.63	1.88	2.25	2.29
Return on Equity (ROE)	-	-881.26%	-36.06%	-85.96%	5.45%	19.50%
Return on Assets (ROA)	6.85%	6.24%	4.67%	3.23%	3.41%	2.37%
Return on Capital (ROIC)	9.04%	8.12%	5.78%	3.95%	4.08%	2.81%
Return on Capital Employed (ROCE)	16.40%	14.70%	10.30%	6.60%	6.60%	4.40%
Earnings Yield	0.13%	-4.76%	-4.51%	-43.12%	1.49%	13.50%
FCF Yield	10.62%	9.57%	16.06%	5.41%	26.68%	47.01%
Buyback Yield / Dilution	-24.70%	-75.42%	-16.69%	0.58%	-1.95%	-12.72%
Total Shareholder Return	-24.70%	-75.42%	-16.69%	0.58%	-1.95%	-12.72%

Updated Aug 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q